000 02320cam a2200325 a 4500
003 EG-GiCUC
008 190716s2019 ua dh f m 000 0 eng d
040 _aEG-GiCUC
_beng
_cEG-GiCUC
041 0 _aeng
049 _aDeposite
097 _aM.Sc
099 _aCai01.12.21.M.Sc.2019.No.R
100 0 _aNoura Elhusseiny Bauomy Mohamed
245 1 0 _aRole of syndecan-1 in modulating the interaction between monocytes and breast cancer stem cells /
_cNoura Elhusseiny Bauomy Mohamed ; Supervised Mona Mostafa Mohamed , Noha Ahmed Mahana , Sherif Abdelaziz Ibrahim
246 1 5 _aدور السينديكان-١ فى تعديل التفاعل بين الخلايا احادية النواة و الخلايا الجذعية لسرطان الثدى
260 _aCairo :
_bNoura Elhusseiny Bauomy Mohamed ,
_c2019
300 _a81 P. :
_bcharts , facsimiles ;
_c25cm
502 _aThesis (M.Sc.) - Cairo University - Faculty of Science - Department of Zoology
520 _aInflammatory breast cancer (IBC) is the most aggressive form of breast cancer and is characterized by a high infiltration of CD14+ monocytes. A growing body of evidence indicates that tumor-associated macrophages (TAMs) are classified into two major phenotypes, tumor inhibiting M1 and tumor promoting M2. The transmembrane heparan sulfate proteoglycan Syndecan-1 (Sdc-1) expression is induced in a variety of cell types during development and tumor progression and plays an essential role in regulation, recruitment and activation of monocytes in tumor microenvironment. We have recently shown that Sdc-1 is overexpressed in tumor tissue samples of IBC vs non-IBC. However, the role of Syndecan-1 in mediating macrophage polarization is still poorly studied. In the present study, we have employed siRNA approach to silence Syndecan-1 expression in the human breast cancer cell lines MDA-MB-231 (non-IBC) and SUM- 149 (IBC) cells
530 _aIssued also as CD
653 4 _aInflammatory breast cancer
653 4 _aSyndecan-1
653 4 _aTmor-associated macrophages and Monocytes
700 0 _aMona Mostafa Mohamed ,
_eSupervisor
700 0 _aNoha Ahmed Mahana ,
_eSupervisor
700 0 _aSherif Abdelaziz Ibrahim ,
_eSupervisor
905 _aNazla
_eRevisor
905 _aShimaa
_eCataloger
942 _2ddc
_cTH
999 _c72882
_d72882